EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hirudin inhibits glioma growth through mTOR ‐regulated autophagy

Ying Ma, Senbin Wu, Fanyi Zhao, Huifeng Li, Qiaohong Li, Jingzhi Zhang, Hua Li, Zhongmin Yuan iD

Journal of Cellular and Molecular Medicine · 2023-09 · 27 (18) · 2701-2713

DOI: 10.1111/jcmm.17851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 04.08.2023. Verfasst von Ying Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Edu…. Hauptthemen laut MEDLINE: Hirudins, Glioma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioma is the most common primary malignant brain tumour, and survival is poor. Hirudin has anticancer pharmacological effects through suppression of glioma cell progression, but the molecular target and mechanism are poorly understood. In this study, we observed that hirudin dose‐ and time‐dependently inhibited glioma invasion, migration and proliferation. Mechanistically, hirudin activated LC3‐II but not Caspase‐3 to induce the autophagic death of glioma cells by decreasing the phosphorylation of mTOR and its downstream substrates ULK1, P70S6K and 4EBP1. Furthermore, hirudin inhibited glioma growth and induced changes in autophagy in cell‐derived xenograft (CDX) nude mice, with a decrease in mTOR activity and activation of LC3‐II. Collectively, our results highlight a new anticancer mechanism of hirudin in which hirudin‐induced inhibition of glioma progression through autophagy activation is likely achieved by inhibition of the mTOR signalling pathway, thus providing a molecular basis for hirudin as a potential and effective clinical drug for glioma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HirudinsGliomaMiceAnimalsHumansMice, NudeCell Line, TumorTOR Serine-Threonine KinasesCell ProliferationAutophagyApoptosis

Stichwörter der Autor:innen

HirudinapoptosisautophagygliomamTOR

Substanzen

HirudinsTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical Uni…
  • Guangdong Province Key Laboratory of Brain Function and Disease, Guangzhou, China.
  • Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Laboratory animal center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangzhou, China.

ORCID-Profile: Zhongmin Yuan

Zitieren

APA

Ma, Y., Wu, S., Zhao, F., Li, H., Li, Q., Zhang, J., Li, H., & Yuan, Z. (2023). Hirudin inhibits glioma growth through mTOR ‐regulated autophagy. Journal of Cellular and Molecular Medicine, 27(18), 2701-2713. https://doi.org/10.1111/jcmm.17851

Vancouver

Ma Y, Wu S, Zhao F, Li H, Li Q, Zhang J, et al. Hirudin inhibits glioma growth through mTOR ‐regulated autophagy. Journal of Cellular and Molecular Medicine. 2023;27(18):2701-2713. doi:10.1111/jcmm.17851

BibTeX
@article{Ma2023,
  author = {Ma, Ying and Wu, Senbin and Zhao, Fanyi and Li, Huifeng and Li, Qiaohong and Zhang, Jingzhi and Li, Hua and Yuan, Zhongmin},
  title = {Hirudin inhibits glioma growth through mTOR ‐regulated autophagy},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  volume = {27},
  number = {18},
  pages = {2701--2713},
  doi = {10.1111/jcmm.17851}
}
Kostenlos starten →